The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 03, 2006
Filed:
Jun. 06, 1995
Luc Montagnier, Le Plessis Robinson, FR;
Solange Chamaret, Paris, FR;
Denise Guetard, Paris, FR;
Marc Alizon, Paris, FR;
François Clavel, Paris, FR;
Mireille Guyader, Paris, FR;
Pierre Sonigo, Paris, FR;
Francoise Brun-vezinet, Paris, FR;
Marianne Rey, Paris, FR;
Christine Rouzioux, Paris, FR;
Christine Katlama, Paris, FR;
Luc Montagnier, Le Plessis Robinson, FR;
Solange Chamaret, Paris, FR;
Denise Guetard, Paris, FR;
Marc Alizon, Paris, FR;
François Clavel, Paris, FR;
Mireille Guyader, Paris, FR;
Pierre Sonigo, Paris, FR;
Francoise Brun-Vezinet, Paris, FR;
Marianne Rey, Paris, FR;
Christine Rouzioux, Paris, FR;
Christine Katlama, Paris, FR;
Institut Pasteur, Paris, FR;
Abstract
The invention relates to a new class of retroviruses, designated by HIV-2, of which samples have been deposited to the ECACC under numbers 87.01.1001 and 87.01.1002 and to the NCIB under numbers 12.398 and 12.399. It relates also to antigens capable to be obtained from this virus, particularly proteins p12, p16, p26 and gp140. These various antigens can be used for the diagnosis of the disease, especially by contacting these antigens with a serum of a patient submitted to the diagnosis. It relates to immunogenic compositions containing more particularly the glycoprotein gp140. Finally it concerns nucleotidic sequences, which can be used especially as hybridization probes, derived from the RNA of HIV-2.